MétaCan
← all works

Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline

2018· article· en· 197 citations· W2889865404 on OpenAlex· 10.1200/jco.18.00606

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.

The three-model screen

all 1,000 screened works →

All three models called this out of scope.

stratum: aff_core · design weight: 5595.24 (the sample is stratified; any rate computed without the weight is wrong)
Claude Opus 4.8OUT
genre: policy
about Canada: no
confidence: high

ASCO endorsement of a clinical practice guideline for localized prostate cancer; a position document about clinical care, not about research practice.

GPT-5.6 (high)OUT
genre: policy
about Canada: no
confidence: high

The article endorses a prostate cancer clinical guideline and does not study research itself.

Grok 4.5OUT
genre: policy
about Canada: no
confidence: high

Clinical practice guideline endorsement for prostate cancer care, not study of research methods or systems.

Abstract

PURPOSE: In April 2017, the American Urological Association, American Society for Radiation Oncology, and Society of Urologic Oncology released a joint evidence-based practice guideline on clinically localized prostate cancer. The American Society of Clinical Oncology (ASCO) has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. METHODS: The Clinically Localized Prostate Cancer guideline was reviewed for developmental rigor by methodologists. An ASCO Expert Panel then reviewed the content and the recommendations. RESULTS: The ASCO Expert Panel determined that the recommendations from the Clinically Localized Prostate Cancer guideline were clear, thorough, and based upon the most relevant scientific evidence. ASCO endorsed the Clinically Localized Prostate Cancer guideline except for two recommendations on cryosurgery. The two recommendations covering cryosurgery were not endorsed because the panel found that there is insufficient evidence to support the use of cryotherapy in this setting. RECOMMENDATIONS: The ASCO Expert Panel endorsed all but two of the original guideline recommendations as written and offered a series of discussion points to guide practice.

Stored with the screening record, where it is evidence for the labels above.

The record

Venue
Journal of Clinical Oncology
Topic
Prostate Cancer Diagnosis and Treatment
Field
Medicine
Canadian institutions
Princess Margaret Cancer Centre
Funders
American Society of Clinical OncologyAmerican Society for Radiation Oncology
Keywords
GuidelineMedicineProstate cancerClinical OncologyOncologyFamily medicineRadiation oncologyInternal medicineCryotherapyProfessional associationCancerMedical physicsRadiation therapySurgeryPathology
Has abstract in OpenAlex
yes